Literature DB >> 17031671

Roles of EGFR-Stat3 signal pathway in carcinogenesis of experimental hepatoma in rats.

Xiao Tang Yu1, Shi Neng Zhu, Zu De Xu, Xi Qi Hu, Teng Fang Zhu, Jie Qing Chen, Shi Lun Lu.   

Abstract

The purpose of this study is to investigate if the EGFR-Stat3 signal pathway contributes to the carcinogenesis of hepatoma in rats. Hepatoma was induced in rats by 3'Me-DAB as a model. EGFR, TGFalpha, Stat3, p-Stat3 in different stages of carcinogenesis were detected by immunohistochemistry and Western blot. In situ hybridization was applied to investigate the expression of Stat3 mRNA. The expressions of signal molecules were assessed by KS400 Image Analysis system. The data were statistically evaluated. EGFR, TGFalpha, Stat3 were highly expressed in the stages of liver necrosis and repairment. All hepatocellular carcinoma cases revealed elevated expression of EGFR, TGFalpha. Elevation of Stat3 mRNA and protein levels were identified, increase of activation of Stat3 was also observed. In HCC, there was positive correlation between p-Stat3 level and the expression of TGFalpha and PCNA. Increased expression of Bcl-2 (P < 0.05) coincided with elevated level of p-Stat3. Therefore, the EGFR-Stat3 signal pathway was related to the development of hepatoma in rats. TGFalpha-EGFR autocrine ring formation may lead to the activation of Stat3 and in turn, promote proliferation and regulate the transcription of genes regulating cell apoptosis and cell cycle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17031671     DOI: 10.1007/s00432-006-0139-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  22 in total

1.  Differential regenerative response and expression of growth factors following hepatectomy of variable extent in rats.

Authors:  S Masson; M Daveau; M Hiron; S Lyoumi; J P Lebreton; P Ténière; M Scotté
Journal:  Liver       Date:  1999-08

Review 2.  EGF mutant receptor vIII as a molecular target in cancer therapy.

Authors:  C T Kuan; C J Wikstrand; D D Bigner
Journal:  Endocr Relat Cancer       Date:  2001-06       Impact factor: 5.678

3.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

4.  Increased activity and expression of MAP kinase in HCC model rats induced by 3'-methyl-4-dimethylamino-azobenzene.

Authors:  M Toyoda; N Hashimoto; K Tokita; B J Goldstein; O Yokosuka; A Kanatsuka; Y Suzuki; Y Saito
Journal:  J Hepatol       Date:  1999-10       Impact factor: 25.083

Review 5.  EGFR-mediated cell cycle regulation.

Authors:  Vivian Wai Yan Lui; Jennifer Rubin Grandis
Journal:  Anticancer Res       Date:  2002 Jan-Feb       Impact factor: 2.480

6.  Distinct amplification of an untranslated regulatory sequence in the egfr gene contributes to early steps in breast cancer development.

Authors:  Nicola Tidow; Almuth Boecker; Hartmut Schmidt; Konstantin Agelopoulos; Werner Boecker; Horst Buerger; Burkhard Brandt
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

Review 7.  STAT proteins: from normal control of cellular events to tumorigenesis.

Authors:  Valentina Calò; Manuela Migliavacca; Viviana Bazan; Marcella Macaluso; Maria Buscemi; Nicola Gebbia; Antonio Russo
Journal:  J Cell Physiol       Date:  2003-11       Impact factor: 6.384

8.  Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis.

Authors:  Keith Syson Chan; Steve Carbajal; Kaoru Kiguchi; John Clifford; Shigetoshi Sano; John DiGiovanni
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

9.  Development of liver tumors in transforming growth factor alpha transgenic mice.

Authors:  G H Lee; G Merlino; N Fausto
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

10.  Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro.

Authors:  J R Grandis; S D Drenning; A Chakraborty; M Y Zhou; Q Zeng; A S Pitt; D J Tweardy
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

View more
  9 in total

1.  Growth hormone modulation of EGF-induced PI3K-Akt pathway in mice liver.

Authors:  Ma Eugenia Díaz; Lorena González; Johanna G Miquet; Carolina S Martínez; Ana I Sotelo; Andrzej Bartke; Daniel Turyn
Journal:  Cell Signal       Date:  2011-10-14       Impact factor: 4.315

2.  Two serine residues of non-metastasis protein 23-H1 are critical in inhibiting signal transducer and activator of transcription 3 activity in human lung cancer cells.

Authors:  Zhihao Wu; Lili Guo; Jiangnan Ge; Zhijian Zhang; Huijun Wei; Qinghua Zhou
Journal:  Oncol Lett       Date:  2017-06-09       Impact factor: 2.967

3.  Growth suppression of human hepatocellular carcinoma xenografts by a monoclonal antibody CH12 directed to epidermal growth factor receptor variant III.

Authors:  Hua Jiang; Huamao Wang; Zhonghua Tan; Suwen Hu; Hai Wang; Bizhi Shi; Lin Yang; Peiyong Li; Jianren Gu; Hongyang Wang; Zonghai Li
Journal:  J Biol Chem       Date:  2010-12-16       Impact factor: 5.157

4.  Elevated expression of ISY1, APOA-1, SYNE1, MTG1, and MMP10 at HCC initiation: HCC specific protein network involving interactions of key regulators of lipid metabolism, EGFR signaling, MAPK, and splicing pathways.

Authors:  Laila H Faraj Shaglouf; Maryam Ranjpour; Saima Wajid; Rakesh Tandon; Karisangal Ramaswamy Vasudevan; Swatantra Kumar Jain
Journal:  Protoplasma       Date:  2022-08-12       Impact factor: 3.186

5.  Expression and activation of EGFR and STAT3 during the multistage carcinogenesis of intrahepatic cholangiocarcinoma induced by 3'-methyl-4 dimethylaminoazobenzene in rats.

Authors:  Fan Zhang; Lianhong Li; Xingwu Yang; Bo Wang; Jinyao Zhao; Shilun Lu; Xiaotang Yu
Journal:  J Toxicol Pathol       Date:  2015-02-09       Impact factor: 1.628

6.  Epidermal growth factor receptor expression and gene copy number analysis in gastric carcinoma samples from Chinese patients.

Authors:  Fan Zhang; Xingwu Yang; Lianhong Li; Lei Sun; B O Wang; Xiaotang Yu
Journal:  Oncol Lett       Date:  2015-11-05       Impact factor: 2.967

7.  Protein tyrosine phosphatase receptor-type δ acts as a negative regulator suppressing breast cancer.

Authors:  Xiaotang Yu; Fan Zhang; Jun Mao; Ying Lu; Jiazhi Li; Wei Ma; Shujun Fan; Chunying Zhang; Qing Li; Bo Wang; Bo Song; Lianhong Li
Journal:  Oncotarget       Date:  2017-10-24

8.  Apoptosis induced by knockdown of uPAR and MMP-9 is mediated by inactivation of EGFR/STAT3 signaling in medulloblastoma.

Authors:  Ramaprasada Rao Kotipatruni; Arun Kumar Nalla; Swapna Asuthkar; Christopher S Gondi; Dzung H Dinh; Jasti S Rao
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

9.  Exposure of Barrett's and esophageal adenocarcinoma cells to bile acids activates EGFR-STAT3 signaling axis via induction of APE1.

Authors:  Ajaz A Bhat; Heng Lu; Mohammed Soutto; Anthony Capobianco; Priyamvada Rai; Alexander Zaika; Wael El-Rifai
Journal:  Oncogene       Date:  2018-07-10       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.